Medpace Holdings, Inc.

NasdaqGS:MEDP Stock Report

Market Cap: US$9.9b

Medpace Holdings Future Growth

Future criteria checks 3/6

Medpace Holdings is forecast to grow earnings and revenue by 9.5% and 9.2% per annum respectively. EPS is expected to grow by 9.1% per annum. Return on equity is forecast to be 40.1% in 3 years.

Key information

9.5%

Earnings growth rate

9.1%

EPS growth rate

Life Sciences earnings growth16.0%
Revenue growth rate9.2%
Future return on equity40.1%
Analyst coverage

Good

Last updated13 Mar 2025

Recent future growth updates

Medpace Holdings, Inc. Just Recorded A 5.6% EPS Beat: Here's What Analysts Are Forecasting Next

Feb 14
Medpace Holdings, Inc. Just Recorded A 5.6% EPS Beat: Here's What Analysts Are Forecasting Next

Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Jul 25
Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Recent updates

Medpace Holdings, Inc. Just Recorded A 5.6% EPS Beat: Here's What Analysts Are Forecasting Next

Feb 14
Medpace Holdings, Inc. Just Recorded A 5.6% EPS Beat: Here's What Analysts Are Forecasting Next

Medpace: Impressive Revenue Growth, High ROE Values, And High Growth Potential

Feb 06

Medpace Holdings, Inc.'s (NASDAQ:MEDP) Price Is Out Of Tune With Earnings

Jan 28
Medpace Holdings, Inc.'s (NASDAQ:MEDP) Price Is Out Of Tune With Earnings

Here's Why Medpace Holdings (NASDAQ:MEDP) Has Caught The Eye Of Investors

Dec 26
Here's Why Medpace Holdings (NASDAQ:MEDP) Has Caught The Eye Of Investors

Is Now The Time To Look At Buying Medpace Holdings, Inc. (NASDAQ:MEDP)?

Nov 22
Is Now The Time To Look At Buying Medpace Holdings, Inc. (NASDAQ:MEDP)?

Medpace: Buy The Short-Term Pain For Long-Term Gains

Oct 26

Why Medpace Holdings Is A 'Better Mousetrap'

Oct 16

Medpace Holdings, Inc.'s (NASDAQ:MEDP) Earnings Haven't Escaped The Attention Of Investors

Sep 19
Medpace Holdings, Inc.'s (NASDAQ:MEDP) Earnings Haven't Escaped The Attention Of Investors

Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?

Sep 02
Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?

Medpace: Continued Business Growth With Asymmetrical Payoff Opportunity

Aug 20

Why Medpace Holdings' (NASDAQ:MEDP) Earnings Are Better Than They Seem

Jul 31
Why Medpace Holdings' (NASDAQ:MEDP) Earnings Are Better Than They Seem

Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Jul 25
Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

What You Can Learn From Medpace Holdings, Inc.'s (NASDAQ:MEDP) P/E

Jun 18
What You Can Learn From Medpace Holdings, Inc.'s (NASDAQ:MEDP) P/E

Medpace: Clear Winner If China Blockade Succeeds

Jun 04

A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)

May 22
A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)

Does Medpace Holdings (NASDAQ:MEDP) Deserve A Spot On Your Watchlist?

Apr 12
Does Medpace Holdings (NASDAQ:MEDP) Deserve A Spot On Your Watchlist?

Medpace: Exceptional Performance, Almost Fully Priced In

Mar 11

Earnings and Revenue Growth Forecasts

NasdaqGS:MEDP - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20272,6584886336708
12/31/20262,38643554858511
12/31/20252,16239041845310
12/31/20242,109404572609N/A
9/30/20242,071366536575N/A
6/30/20242,030340503540N/A
3/31/20241,963312473506N/A
12/31/20231,886283397433N/A
9/30/20231,782273378414N/A
6/30/20231,673268373408N/A
3/31/20231,563257385422N/A
12/31/20221,460245351388N/A
9/30/20221,374227286322N/A
6/30/20221,286209250286N/A
3/31/20221,213199221252N/A
12/31/20211,142181235263N/A
9/30/20211,094182271298N/A
6/30/20211,028175256285N/A
3/31/2021955159235267N/A
12/31/2020926145227259N/A
9/30/2020896124181210N/A
6/30/2020882107188215N/A
3/31/2020891110196217N/A
12/31/2019861100184202N/A
9/30/201982393169184N/A
6/30/201978688160173N/A
3/31/201974278153167N/A
12/31/201870573141157N/A
9/30/201861261N/A146N/A
6/30/201853152N/A132N/A
3/31/201845645N/A121N/A
12/31/201738639N/A97N/A
9/30/201738228N/A98N/A
6/30/201737923N/A101N/A
3/31/201737718N/A78N/A
12/31/201637113N/A92N/A
9/30/20163615N/A91N/A
6/30/20163480N/A80N/A
3/31/2016332-5N/A94N/A
12/31/2015320-9N/A86N/A
12/31/2014290-16N/A75N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MEDP's forecast earnings growth (9.5% per year) is above the savings rate (2.8%).

Earnings vs Market: MEDP's earnings (9.5% per year) are forecast to grow slower than the US market (13.9% per year).

High Growth Earnings: MEDP's earnings are forecast to grow, but not significantly.

Revenue vs Market: MEDP's revenue (9.2% per year) is forecast to grow faster than the US market (8.5% per year).

High Growth Revenue: MEDP's revenue (9.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: MEDP's Return on Equity is forecast to be very high in 3 years time (40.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/16 06:55
End of Day Share Price 2025/03/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medpace Holdings, Inc. is covered by 18 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Eric ColdwellBaird
Ishan MajumdarBaptista Research
Erin Wilson WrightCredit Suisse